Rao, Jia <br/><br/>
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.  [electronic resource] 

 -  Journal of translational medicine  May 2011 
 - 71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/1479-5876-9-71  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antigens, CD34--metabolism<br/>Apoptosis--drug effects<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Curcumin--pharmacology<br/>Daunorubicin--pharmacology<br/>Drug Resistance, Neoplasm--drug effects<br/>Drug Synergism<br/>Female<br/>G1 Phase--drug effects<br/>Gene Expression Regulation, Leukemic--drug effects<br/>Humans<br/>Leukemia, Myeloid, Acute--enzymology<br/>Male<br/>Membrane Potential, Mitochondrial--drug effects<br/>Middle Aged<br/>Poly(ADP-ribose) Polymerases--metabolism<br/>Protein Processing, Post-Translational--drug effects<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>RNA, Messenger--genetics<br/>RNA, Small Interfering--metabolism<br/>S Phase--drug effects